Forte Biosciences (FBRX) IV elevated into data

Forte Biosciences (NASDAQ: FBRX) September call option implied volatility is at 410, October is at 310; compared to its 52-week range of 87 to 365 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis. Call put ratio 1 call to 1.1 puts.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Oxford Industries (OXM) call put ratio 1 call to 5.8 puts to 1 put with a focus on June 30 puts as share price down 19%
• Southern Copper Corp. (SCCO) call put ratio 1.1 calls to 1.3 puts as share price up 3.4%